2013 Template Logo
 
 
  Newsletter
September 21, 2014
 
Americans Speak in Favor of Affordable Medicine

Two newspapers have published opinions by local residents who point to prescription drug importation as the right way to afford medication. Tom Kennedy writes in the Billings Gazette that costs continue to skyrocket in the U.S., and David Di Saia writes in The Valley Breeze that an international pharmacy has made his medication affordable, something his Medicare plan couldn't do.

Your continued online access to more affordable medication is in danger. Drug companies are lobbying Congress and working with the federal government to shut down safe international pharmacies - not just rogue sites. If you have found that ordering from an international pharmacy has helped you, write to your local newspaper and elected leaders. You can find your Federal Senators and Representatives, as well as their contact information, here.


Specialty Drugs Likely to Stay Expensive

Specialty drugs, like those for hepatitis, cancer, or M.S. are repeatedly in the news for their jaw-dropping prices; the most recent example being the Hepatitis C drug Sovaldi. Fortunately, some of these drugs have gone generic - but that doesn't mean they are affordable.

We took a look at some research that studied how access to specialty meds changed once generic versions were introduced. You can read our thoughts on our blog, but be warned: you won't find $4 specialty meds anytime soon.


What Does Sovaldi Mean for Future Coverage of Specialty Drugs

We just wrote part 2 in our series of how to pay for Sovaldi, which looks at options for those with health insurance. Even if you're not in the market for Sovaldi, you might want to take a look at the post. The special conditions required to get your health insurance to cover Sovaldi are extensive, and there may be similar requirements for other specialty drugs. Read the post here.


FB-f-Logo__blue_29  [twitter logo]  Connect with PharmacyChecker.com

Looking to share stories or articles on drug affordability, pricing, or safety? Join us on Facebook or Twitter.